Comparing cardiovascular treatment outcomes across wealthy countries
Official title: Comparing approval, adoption/de-adoption and outcomes for advanced cardiovascular procedures across high-income countries
Funded at Harvard Medical School · NIH-11041134 · Data updated 2026-11-12
This study looks at how new heart treatments are approved and used in wealthy countries, aiming to find out why patients in the US often have worse heart health outcomes despite spending more on healthcare, so that we can improve treatment and policies for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | February 21, 2024 |
| Project end | January 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $574,053 |
| NIH project number | 5R01HL167887-02 |
| Project ID | NIH-11041134 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include patients with cardiovascular conditions such as abdominal aortic aneurysms, acute myocardial infarctions, and those requiring advanced cardiovascular procedures.
✕Less likely to help
Patients with non-cardiovascular conditions or those not undergoing advanced cardiovascular procedures may not benefit from this research.
What this research studies
This research investigates how advanced cardiovascular procedures are approved and adopted in high-income countries, focusing on the differences in outcomes for patients. By analyzing health technology assessments (HTA) and their impact on the use of new treatments, the study aims to understand why the US has poorer cardiovascular outcomes despite higher healthcare spending. Patients may benefit from insights that could lead to improved treatment protocols and better healthcare policies. The research will involve collaboration with international health systems to gather and compare data.
Why it matters
Potential benefit: If successful, this research could lead to improved cardiovascular treatment strategies and policies that enhance patient outcomes.
How similar studies have gone: Previous research has shown that health technology assessments can significantly impact treatment adoption and patient outcomes, indicating a promising approach for this study.
Where this research is happening
-
Harvard Medical School
Boston, United States Active
Researchers
- Principal investigator: Landon, Bruce E. — Harvard Medical School
- Study coordinator: Landon, Bruce E.
Related research
Other NIH-funded projects on the same topics.
-
Comparing End-of-Life Care for Older Adults Across Richer Countries
Aims to understand how end-of-life care for older adults with serious illnesses differs in the US compared with other high-income countries.
-
Comparing End-of-Life Care for Older Adults Across Rich Countries
A study compares how end-of-life care is handled for older adults in the US and other high-income countries to identify what might improve care here.
-
Comparing End-of-Life Care for Older Adults in Rich Countries
A large study from Harvard Medical School compares how older adults near the end of life are cared for in the US and other top-income countries to understand differences and improve care.
-
Comparing End-of-Life Care for Older Adults Across Rich Countries
A study using international data to understand how end-of-life care for older adults with poor prognoses differs across five high‑income countries.
-
Comparing End-of-Life Care for Older Adults Across Rich Countries
A research project compares how older adults with serious illnesses receive end-of-life care in the US and other high-income countries to find ways to improve care in the United States.
-
Comparing End-of-Life Care for Older Adults Across Rich Countries
A project compares how older adults near the end of life are cared for in the U.S. and other high-income countries to identify ways to improve care and reduce wasteful spending.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.